

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | epoxygenase P450 pathway (GO:0019373) | 7.52840204 |
| 2 | omega-hydroxylase P450 pathway (GO:0097267) | 6.32733254 |
| 3 | exogenous drug catabolic process (GO:0042738) | 6.29613050 |
| 4 | drug catabolic process (GO:0042737) | 5.90042730 |
| 5 | fat-soluble vitamin biosynthetic process (GO:0042362) | 5.69592132 |
| 6 | complement activation, alternative pathway (GO:0006957) | 5.69407020 |
| 7 | cellular extravasation (GO:0045123) | 5.51935236 |
| 8 | urea metabolic process (GO:0019627) | 5.33113015 |
| 9 | glyoxylate metabolic process (GO:0046487) | 5.08998433 |
| 10 | ribosomal small subunit assembly (GO:0000028) | 5.07081131 |
| 11 | regulation of triglyceride catabolic process (GO:0010896) | 4.97111053 |
| 12 | nitrogen cycle metabolic process (GO:0071941) | 4.89709344 |
| 13 | urea cycle (GO:0000050) | 4.84696938 |
| 14 | drug metabolic process (GO:0017144) | 4.84224263 |
| 15 | regulation of protein activation cascade (GO:2000257) | 4.65027927 |
| 16 | regulation of fibrinolysis (GO:0051917) | 4.60017414 |
| 17 | regulation of complement activation (GO:0030449) | 4.43199125 |
| 18 | CENP-A containing nucleosome assembly (GO:0034080) | 4.41690463 |
| 19 | negative regulation of fibrinolysis (GO:0051918) | 4.37513925 |
| 20 | ethanol oxidation (GO:0006069) | 4.33541840 |
| 21 | negative regulation of fibroblast apoptotic process (GO:2000270) | 4.26653601 |
| 22 | positive regulation of triglyceride lipase activity (GO:0061365) | 4.18171776 |
| 23 | positive regulation of lipoprotein lipase activity (GO:0051006) | 4.18171776 |
| 24 | L-phenylalanine catabolic process (GO:0006559) | 4.16874298 |
| 25 | erythrose 4-phosphate/phosphoenolpyruvate family amino acid catabolic process (GO:1902222) | 4.16874298 |
| 26 | chromatin remodeling at centromere (GO:0031055) | 4.15508808 |
| 27 | somatic hypermutation of immunoglobulin genes (GO:0016446) | 4.14825584 |
| 28 | somatic diversification of immune receptors via somatic mutation (GO:0002566) | 4.14825584 |
| 29 | acute-phase response (GO:0006953) | 4.10684982 |
| 30 | DNA strand elongation involved in DNA replication (GO:0006271) | 4.09978714 |
| 31 | DNA unwinding involved in DNA replication (GO:0006268) | 4.08108801 |
| 32 | protein carboxylation (GO:0018214) | 4.02554056 |
| 33 | peptidyl-glutamic acid carboxylation (GO:0017187) | 4.02554056 |
| 34 | serine family amino acid catabolic process (GO:0009071) | 4.01826597 |
| 35 | glycine metabolic process (GO:0006544) | 4.01663027 |
| 36 | killing of cells in other organism involved in symbiotic interaction (GO:0051883) | 3.99753491 |
| 37 | disruption of cells of other organism involved in symbiotic interaction (GO:0051818) | 3.99753491 |
| 38 | L-phenylalanine metabolic process (GO:0006558) | 3.95194450 |
| 39 | erythrose 4-phosphate/phosphoenolpyruvate family amino acid metabolic process (GO:1902221) | 3.95194450 |
| 40 | cellular glucuronidation (GO:0052695) | 3.93435836 |
| 41 | telomere maintenance via semi-conservative replication (GO:0032201) | 3.92485563 |
| 42 | T cell migration (GO:0072678) | 3.89485355 |
| 43 | glucuronate metabolic process (GO:0019585) | 3.86993363 |
| 44 | uronic acid metabolic process (GO:0006063) | 3.86993363 |
| 45 | NADH metabolic process (GO:0006734) | 3.86782472 |
| 46 | DNA strand elongation (GO:0022616) | 3.85738493 |
| 47 | angiotensin maturation (GO:0002003) | 3.84645454 |
| 48 | protein localization to kinetochore (GO:0034501) | 3.84545683 |
| 49 | formation of translation preinitiation complex (GO:0001731) | 3.82871625 |
| 50 | hepatocyte apoptotic process (GO:0097284) | 3.78655043 |
| 51 | mitotic nuclear envelope disassembly (GO:0007077) | 3.77353132 |
| 52 | diacylglycerol metabolic process (GO:0046339) | 3.74344637 |
| 53 | fructose metabolic process (GO:0006000) | 3.73744705 |
| 54 | rRNA modification (GO:0000154) | 3.72990728 |
| 55 | ethanol metabolic process (GO:0006067) | 3.72168719 |
| 56 | hormone catabolic process (GO:0042447) | 3.71750033 |
| 57 | DNA replication-independent nucleosome assembly (GO:0006336) | 3.70075042 |
| 58 | DNA replication-independent nucleosome organization (GO:0034724) | 3.70075042 |
| 59 | IMP biosynthetic process (GO:0006188) | 3.69971005 |
| 60 | regulation of systemic arterial blood pressure by renin-angiotensin (GO:0003081) | 3.66446218 |
| 61 | triglyceride-rich lipoprotein particle remodeling (GO:0034370) | 3.65252261 |
| 62 | phospholipid efflux (GO:0033700) | 3.58578835 |
| 63 | oxidative demethylation (GO:0070989) | 3.57961118 |
| 64 | DNA replication initiation (GO:0006270) | 3.53437267 |
| 65 | rRNA methylation (GO:0031167) | 3.50618196 |
| 66 | maturation of SSU-rRNA (GO:0030490) | 3.48020658 |
| 67 | DNA deamination (GO:0045006) | 3.47472703 |
| 68 | bile acid metabolic process (GO:0008206) | 3.46677311 |
| 69 | mitotic metaphase plate congression (GO:0007080) | 3.44216861 |
| 70 | ribosomal small subunit biogenesis (GO:0042274) | 3.44165322 |
| 71 | mitotic chromosome condensation (GO:0007076) | 3.43448390 |
| 72 | very-low-density lipoprotein particle assembly (GO:0034379) | 3.43216510 |
| 73 | regulation of spindle organization (GO:0090224) | 3.41276722 |
| 74 | negative regulation of sterol transport (GO:0032372) | 3.40876137 |
| 75 | negative regulation of cholesterol transport (GO:0032375) | 3.40876137 |
| 76 | histone exchange (GO:0043486) | 3.40866847 |
| 77 | mitotic sister chromatid segregation (GO:0000070) | 3.40665685 |
| 78 | membrane disassembly (GO:0030397) | 3.40539779 |
| 79 | nuclear envelope disassembly (GO:0051081) | 3.40539779 |
| 80 | telomere maintenance via recombination (GO:0000722) | 3.40043000 |
| 81 | vitamin biosynthetic process (GO:0009110) | 3.37609833 |
| 82 | bile acid and bile salt transport (GO:0015721) | 3.36615139 |
| 83 | nucleobase biosynthetic process (GO:0046112) | 3.36433385 |
| 84 | complement activation (GO:0006956) | 3.36368634 |
| 85 | complement activation, classical pathway (GO:0006958) | 3.32712450 |
| 86 | viral transcription (GO:0019083) | 3.32575651 |
| 87 | translational termination (GO:0006415) | 3.31748541 |
| 88 | attachment of spindle microtubules to kinetochore (GO:0008608) | 3.31488364 |
| 89 | protein activation cascade (GO:0072376) | 3.30080756 |
| 90 | mitotic recombination (GO:0006312) | 3.29992364 |
| 91 | plasma lipoprotein particle assembly (GO:0034377) | 3.29579373 |
| 92 | ribosome biogenesis (GO:0042254) | 3.29475293 |
| 93 | DNA replication checkpoint (GO:0000076) | 3.29289418 |
| 94 | rRNA processing (GO:0006364) | 3.28235550 |
| 95 | ribonucleoprotein complex biogenesis (GO:0022613) | 3.26822366 |
| 96 | IMP metabolic process (GO:0046040) | 3.26660577 |
| 97 | plasma lipoprotein particle remodeling (GO:0034369) | 3.26086627 |
| 98 | protein-lipid complex remodeling (GO:0034368) | 3.26086627 |
| 99 | macromolecular complex remodeling (GO:0034367) | 3.26086627 |
| 100 | protein localization to chromosome, centromeric region (GO:0071459) | 3.24304587 |
| 101 | regulation of bile acid biosynthetic process (GO:0070857) | 3.23874248 |
| 102 | regulation of humoral immune response (GO:0002920) | 3.23064458 |
| 103 | ribosomal large subunit biogenesis (GO:0042273) | 3.23046736 |
| 104 | imidazole-containing compound metabolic process (GO:0052803) | 3.22588283 |
| 105 | folic acid-containing compound biosynthetic process (GO:0009396) | 3.22474556 |
| 106 | cytolysis (GO:0019835) | 3.21930035 |
| 107 | proline metabolic process (GO:0006560) | 3.21249449 |
| 108 | coenzyme catabolic process (GO:0009109) | 3.20410853 |
| 109 | mast cell activation involved in immune response (GO:0002279) | 3.19632511 |
| 110 | mast cell degranulation (GO:0043303) | 3.19632511 |
| 111 | opsonization (GO:0008228) | 3.18677874 |
| 112 | regulation of transcription involved in G1/S transition of mitotic cell cycle (GO:0000083) | 3.18087630 |
| 113 | deoxyribonucleoside monophosphate metabolic process (GO:0009162) | 3.17916559 |
| 114 | purine nucleobase biosynthetic process (GO:0009113) | 3.15553282 |
| 115 | blood coagulation, intrinsic pathway (GO:0007597) | 3.15043390 |
| 116 | DNA replication-dependent nucleosome organization (GO:0034723) | 3.14112841 |
| 117 | DNA replication-dependent nucleosome assembly (GO:0006335) | 3.14112841 |
| 118 | high-density lipoprotein particle remodeling (GO:0034375) | 3.13649880 |
| 119 | translational elongation (GO:0006414) | 3.13240408 |
| 120 | rRNA metabolic process (GO:0016072) | 3.12699457 |
| 121 | antigen processing and presentation of endogenous antigen (GO:0019883) | 3.11809850 |
| 122 | snRNA processing (GO:0016180) | 3.11655277 |
| 123 | sister chromatid segregation (GO:0000819) | 3.11336980 |
| 124 | bile acid biosynthetic process (GO:0006699) | 3.11157389 |
| 125 | antigen processing and presentation of endogenous peptide antigen via MHC class I (GO:0019885) | 3.11030247 |
| 126 | cholesterol efflux (GO:0033344) | 3.09835966 |
| 127 | fibrinolysis (GO:0042730) | 3.07524167 |
| 128 | mucosal-associated lymphoid tissue development (GO:0048537) | 3.07132119 |
| 129 | Peyers patch development (GO:0048541) | 3.07132119 |
| 130 | antigen processing and presentation of endogenous peptide antigen (GO:0002483) | 3.06863640 |
| 131 | nuclear pore organization (GO:0006999) | 3.05025392 |
| 132 | metaphase plate congression (GO:0051310) | 3.04651269 |
| 133 | protein-lipid complex assembly (GO:0065005) | 3.03888220 |
| 134 | telomere maintenance via telomere lengthening (GO:0010833) | 3.01911085 |
| 135 | snRNA metabolic process (GO:0016073) | 3.00848330 |
| 136 | ncRNA 3-end processing (GO:0043628) | 2.99832851 |
| 137 | aromatic amino acid family catabolic process (GO:0009074) | 2.99737398 |
| 138 | translational initiation (GO:0006413) | 2.99140036 |
| 139 | positive regulation of fatty acid biosynthetic process (GO:0045723) | 2.98193777 |
| 140 | lipoprotein transport (GO:0042953) | 2.96480351 |
| 141 | alkaloid metabolic process (GO:0009820) | 2.96453716 |
| 142 | heme transport (GO:0015886) | 2.96438656 |
| 143 | regulation of translational termination (GO:0006449) | 2.95532702 |
| 144 | regulation of cholesterol esterification (GO:0010872) | 2.94451811 |
| 145 | glutamate metabolic process (GO:0006536) | 2.94003729 |
| 146 | kinetochore organization (GO:0051383) | 2.92413024 |
| 147 | regulation of fibroblast apoptotic process (GO:2000269) | 2.92219195 |
| 148 | SRP-dependent cotranslational protein targeting to membrane (GO:0006614) | 2.92188899 |
| 149 | establishment of chromosome localization (GO:0051303) | 2.92152827 |
| 150 | negative regulation of ubiquitin-protein ligase activity involved in mitotic cell cycle (GO:0051436) | 2.91894276 |
| 151 | chromatin assembly or disassembly (GO:0006333) | 2.88774278 |
| 152 | plasma lipoprotein particle organization (GO:0071827) | 2.88416810 |
| 153 | nucleotide-excision repair, DNA gap filling (GO:0006297) | 2.86486964 |
| 154 | anaphase-promoting complex-dependent proteasomal ubiquitin-dependent protein catabolic process (GO:0 | 2.85672458 |
| 155 | serine family amino acid metabolic process (GO:0009069) | 2.85379465 |
| 156 | regulation of humoral immune response mediated by circulating immunoglobulin (GO:0002923) | 2.85185711 |
| 157 | nuclear-transcribed mRNA catabolic process, nonsense-mediated decay (GO:0000184) | 2.84833474 |
| 158 | fatty acid beta-oxidation using acyl-CoA oxidase (GO:0033540) | 2.84439832 |
| 159 | cotranslational protein targeting to membrane (GO:0006613) | 2.83289460 |
| 160 | quinone biosynthetic process (GO:1901663) | 2.82611187 |
| 161 | glutamine family amino acid biosynthetic process (GO:0009084) | 2.82542101 |
| 162 | protoporphyrinogen IX biosynthetic process (GO:0006782) | 2.81291124 |
| 163 | negative regulation of mRNA splicing, via spliceosome (GO:0048025) | 2.80987306 |
| 164 | protein targeting to ER (GO:0045047) | 2.80590603 |
| 165 | regulation of lipoprotein particle clearance (GO:0010984) | 2.80283254 |
| 166 | negative regulation of hemostasis (GO:1900047) | 2.79843801 |
| 167 | negative regulation of blood coagulation (GO:0030195) | 2.79843801 |
| 168 | DNA duplex unwinding (GO:0032508) | 2.79779680 |
| 169 | oxaloacetate metabolic process (GO:0006107) | 2.79747290 |
| 170 | regulation of ubiquitin-protein ligase activity involved in mitotic cell cycle (GO:0051439) | 2.78835466 |
| 171 | RNA splicing, via transesterification reactions (GO:0000375) | 2.78395087 |
| 172 | proline biosynthetic process (GO:0006561) | 2.78003437 |
| 173 | amino-acid betaine metabolic process (GO:0006577) | 2.77002536 |
| 174 | spindle assembly checkpoint (GO:0071173) | 2.76933324 |
| 175 | RNA splicing, via transesterification reactions with bulged adenosine as nucleophile (GO:0000377) | 2.76904030 |
| 176 | mRNA splicing, via spliceosome (GO:0000398) | 2.76904030 |
| 177 | protein-lipid complex subunit organization (GO:0071825) | 2.76898155 |
| 178 | viral mRNA export from host cell nucleus (GO:0046784) | 2.75558419 |
| 179 | negative regulation of chromosome segregation (GO:0051985) | 2.75122457 |
| 180 | somatic diversification of immunoglobulins (GO:0016445) | 2.74674338 |
| 181 | regulation of attachment of spindle microtubules to kinetochore (GO:0051988) | 2.74627746 |
| 182 | cellular protein complex disassembly (GO:0043624) | 2.74064336 |
| 183 | DNA geometric change (GO:0032392) | 2.74054680 |
| 184 | cofactor catabolic process (GO:0051187) | 2.73662748 |
| 185 | negative regulation of ubiquitin-protein transferase activity (GO:0051444) | 2.72996702 |
| 186 | negative regulation of ligase activity (GO:0051352) | 2.72996702 |
| 187 | mitotic spindle assembly checkpoint (GO:0007094) | 2.72590529 |
| 188 | negative regulation of mitotic metaphase/anaphase transition (GO:0045841) | 2.72530194 |
| 189 | negative regulation of sister chromatid segregation (GO:0033046) | 2.72530194 |
| 190 | negative regulation of mitotic sister chromatid separation (GO:2000816) | 2.72530194 |
| 191 | negative regulation of mitotic sister chromatid segregation (GO:0033048) | 2.72530194 |
| 192 | protoporphyrinogen IX metabolic process (GO:0046501) | 2.71772966 |
| 193 | positive regulation of ubiquitin-protein ligase activity involved in mitotic cell cycle (GO:0051437) | 2.70924977 |
| 194 | mismatch repair (GO:0006298) | 2.70664584 |
| 195 | reverse cholesterol transport (GO:0043691) | 2.70407296 |
| 196 | spindle checkpoint (GO:0031577) | 2.70239744 |
| 197 | lipoprotein metabolic process (GO:0042157) | 2.69739132 |
| 198 | mannose metabolic process (GO:0006013) | 2.69574301 |
| 199 | flavonoid metabolic process (GO:0009812) | 2.69057004 |
| 200 | S-adenosylmethionine metabolic process (GO:0046500) | 2.66634381 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | E2F7_22180533_ChIP-Seq_HELA_Human | 6.80974945 |
| 2 | ESR1_17901129_ChIP-ChIP_LIVER_Mouse | 4.83222685 |
| 3 | FOXM1_23109430_ChIP-Seq_U2OS_Human | 4.15925651 |
| 4 | EKLF_21900194_ChIP-Seq_ERYTHROCYTE_Mouse | 4.01466350 |
| 5 | MYC_18555785_ChIP-Seq_MESCs_Mouse | 3.71906945 |
| 6 | E2F4_17652178_ChIP-ChIP_JURKAT_Human | 3.07984082 |
| 7 | RXR_22158963_ChIP-Seq_LIVER_Mouse | 3.07875599 |
| 8 | FOXM1_25889361_ChIP-Seq_OE33_AND_U2OS_Human | 3.05359204 |
| 9 | E4F1_26484288_ChIP-Seq_MOUSE_EMBRYONIC_FIBROBLAST_Mouse | 2.95807998 |
| 10 | PPARA_22158963_ChIP-Seq_LIVER_Mouse | 2.91157122 |
| 11 | EGR1_23403033_ChIP-Seq_LIVER_Mouse | 2.90953991 |
| 12 | KDM6A_18722178_ChIP-ChIP_U937_AND_SAOS2_Human | 2.81665826 |
| 13 | MYC_18358816_ChIP-ChIP_MESCs_Mouse | 2.70292923 |
| 14 | JARID1A_20064375_ChIP-Seq_MESCs_Mouse | 2.67562570 |
| 15 | EST1_17652178_ChIP-ChIP_JURKAT_Human | 2.66726476 |
| 16 | GABP_17652178_ChIP-ChIP_JURKAT_Human | 2.55184180 |
| 17 | MYC_19079543_ChIP-ChIP_MESCs_Mouse | 2.50914171 |
| 18 | NOTCH1_17114293_ChIP-ChIP_T-ALL_Human | 2.48660686 |
| 19 | PPARG_19300518_ChIP-PET_3T3-L1_Mouse | 2.46307074 |
| 20 | ETS1_20019798_ChIP-Seq_JURKAT_Human | 2.46010928 |
| 21 | MYC_19030024_ChIP-ChIP_MESCs_Mouse | 2.42592471 |
| 22 | CREB1_15753290_ChIP-ChIP_HEK293T_Human | 2.35241031 |
| 23 | FOXP3_21729870_ChIP-Seq_TREG_Human | 2.31056105 |
| 24 | SPI1_22790984_ChIP-Seq_ERYTHROLEUKEMIA_Mouse | 2.28464460 |
| 25 | MYC_22102868_ChIP-Seq_BL_Human | 2.22809006 |
| 26 | VDR_23849224_ChIP-Seq_CD4+_Human | 2.22694189 |
| 27 | NELFA_20434984_ChIP-Seq_ESCs_Mouse | 2.22370941 |
| 28 | FOXO1_23066095_ChIP-Seq_LIVER_Mouse | 2.15764805 |
| 29 | LXR_22158963_ChIP-Seq_LIVER_Mouse | 2.11627299 |
| 30 | XRN2_22483619_ChIP-Seq_HELA_Human | 2.11086446 |
| 31 | IRF1_21803131_ChIP-Seq_MONOCYTES_Human | 2.08683684 |
| 32 | HCFC1_20581084_ChIP-Seq_MESCs_Mouse | 2.08253685 |
| 33 | EGR1_19374776_ChIP-ChIP_THP-1_Human | 1.98048240 |
| 34 | TAL1_20887958_ChIP-Seq_HPC-7_Mouse | 1.95237509 |
| 35 | THAP11_20581084_ChIP-Seq_MESCs_Mouse | 1.89163660 |
| 36 | GABP_19822575_ChIP-Seq_HepG2_Human | 1.87697113 |
| 37 | CHD1_19587682_ChIP-ChIP_MESCs_Mouse | 1.85333609 |
| 38 | FOXP3_17237761_ChIP-ChIP_TREG_Mouse | 1.84501162 |
| 39 | E2F1_18555785_ChIP-Seq_MESCs_Mouse | 1.83527991 |
| 40 | ELF1_17652178_ChIP-ChIP_JURKAT_Human | 1.82181847 |
| 41 | SPI1_22096565_ChIP-ChIP_GC-B_Mouse | 1.81267327 |
| 42 | PPARG_23326641_ChIP-Seq_C3H10T1-2_Mouse | 1.80903084 |
| 43 | DCP1A_22483619_ChIP-Seq_HELA_Human | 1.80303056 |
| 44 | MYBL1_21750041_ChIP-ChIP_SPERMATOCYTES_Mouse | 1.80280784 |
| 45 | CIITA_25753668_ChIP-Seq_RAJI_Human | 1.79755989 |
| 46 | MAF_26560356_Chip-Seq_TH2_Human | 1.76723840 |
| 47 | HOXC9_25013753_ChIP-Seq_NEUROBLASTOMA_BE2-C_Human | 1.75181649 |
| 48 | LXR_22292898_ChIP-Seq_THP-1_Human | 1.75036784 |
| 49 | HOXB4_20404135_ChIP-ChIP_EML_Mouse | 1.74400068 |
| 50 | VDR_21846776_ChIP-Seq_THP-1_Human | 1.73604400 |
| 51 | SRF_21415370_ChIP-Seq_HL-1_Mouse | 1.72371320 |
| 52 | FLI1_20887958_ChIP-Seq_HPC-7_Mouse | 1.71606135 |
| 53 | IRF8_21731497_ChIP-ChIP_J774_Mouse | 1.70576005 |
| 54 | AR_21909140_ChIP-Seq_LNCAP_Human | 1.69807633 |
| 55 | FOXO3_22982991_ChIP-Seq_MACROPHAGES_Mouse | 1.69615007 |
| 56 | ASXL1_24218140_ChIP-Seq_BMDM_Mouse | 1.67513318 |
| 57 | STAT6_20620947_ChIP-Seq_CD4_POS_T_Human | 1.65710771 |
| 58 | E2F1_21310950_ChIP-Seq_MCF-7_Human | 1.65677378 |
| 59 | FOXP1_22492998_ChIP-Seq_STRATIUM_Mouse | 1.62815927 |
| 60 | VDR_24763502_ChIP-Seq_THP-1_Human | 1.62450418 |
| 61 | NR1H3_23393188_ChIP-Seq_ATHEROSCLEROTIC-FOAM_Human | 1.60421268 |
| 62 | BP1_19119308_ChIP-ChIP_Hs578T_Human | 1.60257381 |
| 63 | E2A_27217539_Chip-Seq_RAMOS-Cell_line_Human | 1.57854836 |
| 64 | MYBL2_22936984_ChIP-ChIP_MESCs_Mouse | 1.57654407 |
| 65 | TTF2_22483619_ChIP-Seq_HELA_Human | 1.57344185 |
| 66 | CEBPB_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 1.55670343 |
| 67 | MYCN_18555785_ChIP-Seq_MESCs_Mouse | 1.53726813 |
| 68 | IRF8_22096565_ChIP-ChIP_GC-B_Mouse | 1.51269589 |
| 69 | SFPI1_20887958_ChIP-Seq_HPC-7_Mouse | 1.50848353 |
| 70 | ERG_20887958_ChIP-Seq_HPC-7_Mouse | 1.50002353 |
| 71 | BCL6_27268052_Chip-Seq_Bcells_Human | 1.48220731 |
| 72 | CCND1_20090754_ChIP-ChIP_RETINA_Mouse | 1.47926083 |
| 73 | BCOR_27268052_Chip-Seq_Bcells_Human | 1.47345325 |
| 74 | NOTCH1_21737748_ChIP-Seq_TLL_Human | 1.47327989 |
| 75 | YY1_23942234_ChIP-Seq_MYOBLASTS_AND_MYOTUBES_Mouse | 1.47032910 |
| 76 | ZFX_18555785_ChIP-Seq_MESCs_Mouse | 1.45923695 |
| 77 | MECOM_23826213_ChIP-Seq_KASUMI_Mouse | 1.45236204 |
| 78 | KDM5A_27292631_Chip-Seq_BREAST_Human | 1.42589841 |
| 79 | ELK1_19687146_ChIP-ChIP_HELA_Human | 1.40866256 |
| 80 | SOX9_22984422_ChIP-ChIP_TESTIS_Rat | 1.38846303 |
| 81 | PDX1_19855005_ChIP-ChIP_MIN6_Mouse | 1.37173456 |
| 82 | KDM2B_26808549_Chip-Seq_SIL-ALL_Human | 1.36794850 |
| 83 | TAF7L_23326641_ChIP-Seq_C3H10T1-2_Mouse | 1.35884149 |
| 84 | ELF1_20517297_ChIP-Seq_JURKAT_Human | 1.34741351 |
| 85 | HNF4A_19761587_ChIP-ChIP_CACO-2_Human | 1.34023112 |
| 86 | ZFP42_18358816_ChIP-ChIP_MESCs_Mouse | 1.32558491 |
| 87 | POU5F1_18555785_ChIP-Seq_MESCs_Mouse | 1.32093188 |
| 88 | P68_20966046_ChIP-Seq_HELA_Human | 1.31440703 |
| 89 | NCOR_22465074_ChIP-Seq_MACROPHAGES_Mouse | 1.31302279 |
| 90 | CIITA_18437201_ChIP-ChIP_Raji_B_and_iDC_Human | 1.30576678 |
| 91 | ELK3_25401928_ChIP-Seq_HUVEC_Human | 1.30090970 |
| 92 | SMRT_22465074_ChIP-Seq_MACROPHAGES_Mouse | 1.28211197 |
| 93 | YY1_21170310_ChIP-Seq_MESCs_Mouse | 1.27274607 |
| 94 | TFEB_21752829_ChIP-Seq_HELA_Human | 1.27184489 |
| 95 | SPI1_23547873_ChIP-Seq_NB4_Human | 1.26398781 |
| 96 | VDR_23401126_ChIP-Seq_LCL-AND-THP1_Human | 1.25447280 |
| 97 | SCL_19346495_ChIP-Seq_HPC-7_Human | 1.24712068 |
| 98 | TET1_21451524_ChIP-Seq_MESCs_Mouse | 1.23621944 |
| 99 | PU.1_20513432_ChIP-Seq_MACROPHAGES_Mouse | 1.22133996 |
| 100 | RUNX1_20887958_ChIP-Seq_HPC-7_Mouse | 1.22053162 |
| 101 | STAT3_1855785_ChIP-Seq_MESCs_Mouse | 1.19848102 |
| 102 | E2F4_21247883_ChIP-Seq_LYMPHOBLASTOID_Human | 1.18083296 |
| 103 | KDM5B_21448134_ChIP-Seq_MESCs_Mouse | 1.17792709 |
| 104 | CTNNB1_20615089_ChIP-ChIP_FETAL_BRAIN_Human | 1.17175868 |
| 105 | PHF8_20622854_ChIP-Seq_HELA_Human | 1.16579161 |
| 106 | NANOG_18555785_ChIP-Seq_MESCs_Mouse | 1.15629268 |
| 107 | TCF7_22412390_ChIP-Seq_EML_Mouse | 1.15535332 |
| 108 | RACK7_27058665_Chip-Seq_MCF-7_Human | 1.14764868 |
| 109 | CEBPB_20176806_ChIP-Seq_MACROPHAGES_Mouse | 1.14316292 |
| 110 | BCL3_23251550_ChIP-Seq_MUSCLE_Mouse | 1.13821037 |
| 111 | PU.1_20513432_ChIP-Seq_Bcells_Mouse | 1.12719622 |
| 112 | SA1_27219007_Chip-Seq_Bcells_Human | 1.12409369 |
| 113 | RELA_24523406_ChIP-Seq_FIBROSARCOMA_Human | 1.12343026 |
| 114 | KDM2B_26808549_Chip-Seq_HPB-ALL_Human | 1.11703415 |
| 115 | DACH1_20351289_ChIP-Seq_MDA-MB-231_Human | 1.10906903 |
| 116 | MAF_26560356_Chip-Seq_TH1_Human | 1.09007397 |
| 117 | BRD4_27068464_Chip-Seq_AML-cells_Mouse | 1.08728455 |
| 118 | GFI1B_20887958_ChIP-Seq_HPC-7_Mouse | 1.08725211 |
| 119 | SPI1_20517297_ChIP-Seq_HL60_Human | 1.08614250 |
| 120 | ZNF652_21678463_ChIP-ChIP_ZR75-1_Human | 1.07980358 |
| 121 | MEIS1_20887958_ChIP-Seq_HPC-7_Mouse | 1.07916278 |
| 122 | SA1_27219007_Chip-Seq_ERYTHROID_Human | 1.07741711 |
| 123 | CTCF_27219007_Chip-Seq_ERYTHROID_Human | 1.07549501 |
| 124 | PADI4_21655091_ChIP-ChIP_MCF-7_Human | 1.06653367 |
| 125 | SMC4_20622854_ChIP-Seq_HELA_Human | 1.05984656 |
| 126 | CREB1_23762244_ChIP-Seq_HIPPOCAMPUS_Rat | 1.05636342 |
| 127 | GATA1_22025678_ChIP-Seq_K562_Human | 1.05403938 |
| 128 | CEBPB_23403033_ChIP-Seq_LIVER_Mouse | 1.05013742 |
| 129 | KDM2B_26808549_Chip-Seq_DND41_Human | 1.04253555 |
| 130 | NR1I2_20693526_ChIP-Seq_LIVER_Mouse | 1.03867935 |
| 131 | GATA1_22383799_ChIP-Seq_G1ME_Mouse | 1.03806914 |
| 132 | SPI1_23127762_ChIP-Seq_K562_Human | 1.03690877 |
| 133 | IRF8_22096565_ChIP-ChIP_GC-B_Human | 1.03569193 |
| 134 | CTCF_21964334_ChIP-Seq_BJAB-B_Human | 1.03179211 |
| 135 | TBP_23326641_ChIP-Seq_C3H10T1-2_Mouse | 1.03164971 |
| 136 | UTX_26944678_Chip-Seq_JUKART_Human | 1.02995533 |
| 137 | ETS1_21867929_ChIP-Seq_TH2_Mouse | 1.02742071 |
| 138 | GATA2_20887958_ChIP-Seq_HPC-7_Mouse | 1.02052758 |
| 139 | CREB1_20920259_ChIP-Seq_GC1-SPG_Mouse | 1.01900759 |
| 140 | SREBP2_21459322_ChIP-Seq_LIVER_Mouse | 1.01606185 |
| 141 | MYB_26560356_Chip-Seq_TH2_Human | 1.01416022 |
| 142 | CTCF_21964334_Chip-Seq_Bcells_Human | 1.00913224 |
| 143 | MYCN_21190229_ChIP-Seq_SHEP-21N_Human | 1.00670389 |
| 144 | E2F1_20622854_ChIP-Seq_HELA_Human | 1.00476632 |
| 145 | TCF7L2_21901280_ChIP-Seq_H4IIE_Rat | 0.99406353 |
| 146 | P300_27268052_Chip-Seq_Bcells_Human | 0.99061510 |
| 147 | CUX1_19635798_ChIP-ChIP_MULTIPLE_HUMAN_CANCER_TYPES_Human | 0.99002688 |
| 148 | MYB_21317192_ChIP-Seq_ERMYB_Mouse | 0.98616864 |
| 149 | HNF4A_19822575_ChIP-Seq_HepG2_Human | 0.98012857 |
| 150 | RUNX1_22412390_ChIP-Seq_EML_Mouse | 0.97850259 |
| 151 | CEBPB_24764292_ChIP-Seq_MC3T3_Mouse | 0.97799233 |
| 152 | SPI1_26923725_Chip-Seq_MACROPHAGESS_Mouse | 0.97771352 |
| 153 | NCOR1_26117541_ChIP-Seq_K562_Human | 0.96664862 |
| 154 | DMRT1_21621532_ChIP-ChIP_FETAL_Ovary | 0.96223379 |
| 155 | SPI1_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 0.95977672 |
| 156 | STAT4_19710469_ChIP-ChIP_TH1__Mouse | 0.95876942 |
| 157 | GATA1_19941827_ChIP-Seq_MEL_Mouse | 0.95255313 |
| 158 | KLF4_18555785_ChIP-Seq_MESCs_Mouse | 0.92746486 |
| 159 | HSF1_23293686_ChIP-Seq_STHDH_STRIATAL_Mouse | 0.92485839 |
| 160 | MYC_18940864_ChIP-ChIP_HL60_Human | 0.91909208 |
| 161 | MYB_26560356_Chip-Seq_TH1_Human | 0.91821695 |
| 162 | CEBPA_23403033_ChIP-Seq_LIVER_Mouse | 0.91676369 |
| 163 | GATA2_22383799_ChIP-Seq_G1ME_Mouse | 0.88814966 |
| 164 | TAL1_20566737_ChIP-Seq_PRIMARY_FETAL_LIVER_ERYTHROID_Mouse | 0.88263332 |
| 165 | POU5F1_18700969_ChIP-ChIP_MESCs_Mouse | 0.86244441 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MP0005360_urolithiasis | 6.39222016 |
| 2 | MP0002139_abnormal_hepatobiliary_system | 6.29633419 |
| 3 | MP0003693_abnormal_embryo_hatching | 4.38190940 |
| 4 | MP0005365_abnormal_bile_salt | 4.25008950 |
| 5 | MP0010094_abnormal_chromosome_stability | 4.16678734 |
| 6 | MP0005085_abnormal_gallbladder_physiolo | 3.91327632 |
| 7 | MP0003111_abnormal_nucleus_morphology | 3.73659373 |
| 8 | MP0001666_abnormal_nutrient_absorption | 3.47685467 |
| 9 | MP0002396_abnormal_hematopoietic_system | 3.45892929 |
| 10 | MP0003077_abnormal_cell_cycle | 3.28542902 |
| 11 | MP0004957_abnormal_blastocyst_morpholog | 3.14948638 |
| 12 | MP0008875_abnormal_xenobiotic_pharmacok | 3.06175060 |
| 13 | MP0008058_abnormal_DNA_repair | 2.88887676 |
| 14 | MP0008007_abnormal_cellular_replicative | 2.77790906 |
| 15 | MP0003191_abnormal_cellular_cholesterol | 2.52860127 |
| 16 | MP0008057_abnormal_DNA_replication | 2.52619828 |
| 17 | MP0004808_abnormal_hematopoietic_stem | 2.51899442 |
| 18 | MP0003868_abnormal_feces_composition | 2.50146191 |
| 19 | MP0003436_decreased_susceptibility_to | 2.39683283 |
| 20 | MP0003763_abnormal_thymus_physiology | 2.34573123 |
| 21 | MP0004233_abnormal_muscle_weight | 2.30462240 |
| 22 | MP0008877_abnormal_DNA_methylation | 2.28970062 |
| 23 | MP0001764_abnormal_homeostasis | 2.19528155 |
| 24 | MP0010329_abnormal_lipoprotein_level | 2.14837502 |
| 25 | MP0004147_increased_porphyrin_level | 2.13536098 |
| 26 | MP0003656_abnormal_erythrocyte_physiolo | 2.10733279 |
| 27 | MP0005451_abnormal_body_composition | 2.09751815 |
| 28 | MP0002398_abnormal_bone_marrow | 2.09282290 |
| 29 | MP0005058_abnormal_lysosome_morphology | 2.08280891 |
| 30 | MP0002138_abnormal_hepatobiliary_system | 2.07797841 |
| 31 | MP0003806_abnormal_nucleotide_metabolis | 2.06216095 |
| 32 | MP0009333_abnormal_splenocyte_physiolog | 2.02217131 |
| 33 | MP0008932_abnormal_embryonic_tissue | 1.98923160 |
| 34 | MP0003252_abnormal_bile_duct | 1.96401618 |
| 35 | MP0005671_abnormal_response_to | 1.91614533 |
| 36 | MP0004084_abnormal_cardiac_muscle | 1.88147282 |
| 37 | MP0000703_abnormal_thymus_morphology | 1.84728841 |
| 38 | MP0002722_abnormal_immune_system | 1.83040177 |
| 39 | MP0005332_abnormal_amino_acid | 1.82225961 |
| 40 | MP0000689_abnormal_spleen_morphology | 1.75050412 |
| 41 | MP0000609_abnormal_liver_physiology | 1.74642913 |
| 42 | MP0001730_embryonic_growth_arrest | 1.74423007 |
| 43 | MP0001800_abnormal_humoral_immune | 1.72846978 |
| 44 | MP0000350_abnormal_cell_proliferation | 1.72456584 |
| 45 | MP0009840_abnormal_foam_cell | 1.66747700 |
| 46 | MP0005464_abnormal_platelet_physiology | 1.66522425 |
| 47 | MP0001835_abnormal_antigen_presentation | 1.65693276 |
| 48 | MP0001545_abnormal_hematopoietic_system | 1.64798768 |
| 49 | MP0005397_hematopoietic_system_phenotyp | 1.64798768 |
| 50 | MP0000490_abnormal_crypts_of | 1.60388297 |
| 51 | MP0003943_abnormal_hepatobiliary_system | 1.59802590 |
| 52 | MP0002429_abnormal_blood_cell | 1.57562477 |
| 53 | MP0005075_abnormal_melanosome_morpholog | 1.56495559 |
| 54 | MP0003123_paternal_imprinting | 1.55259731 |
| 55 | MP0003786_premature_aging | 1.53994516 |
| 56 | MP0004019_abnormal_vitamin_homeostasis | 1.52838488 |
| 57 | MP0009785_altered_susceptibility_to | 1.50838471 |
| 58 | MP0000716_abnormal_immune_system | 1.47935155 |
| 59 | MP0002452_abnormal_antigen_presenting | 1.46406442 |
| 60 | MP0003195_calcinosis | 1.43134034 |
| 61 | MP0002420_abnormal_adaptive_immunity | 1.42735481 |
| 62 | MP0002019_abnormal_tumor_incidence | 1.42292829 |
| 63 | MP0009697_abnormal_copulation | 1.42159245 |
| 64 | MP0001819_abnormal_immune_cell | 1.39124009 |
| 65 | MP0002118_abnormal_lipid_homeostasis | 1.37082149 |
| 66 | MP0010307_abnormal_tumor_latency | 1.37012493 |
| 67 | MP0002876_abnormal_thyroid_physiology | 1.36171727 |
| 68 | MP0001697_abnormal_embryo_size | 1.35530831 |
| 69 | MP0008469_abnormal_protein_level | 1.34906818 |
| 70 | MP0005000_abnormal_immune_tolerance | 1.33163873 |
| 71 | MP0000685_abnormal_immune_system | 1.32967071 |
| 72 | MP0000313_abnormal_cell_death | 1.30490281 |
| 73 | MP0002723_abnormal_immune_serum | 1.28743745 |
| 74 | MP0002080_prenatal_lethality | 1.28341876 |
| 75 | MP0010352_gastrointestinal_tract_polyps | 1.26547304 |
| 76 | MP0005023_abnormal_wound_healing | 1.26014264 |
| 77 | MP0003303_peritoneal_inflammation | 1.25121186 |
| 78 | MP0009643_abnormal_urine_homeostasis | 1.24122046 |
| 79 | MP0009278_abnormal_bone_marrow | 1.21471530 |
| 80 | MP0005584_abnormal_enzyme/coenzyme_acti | 1.17368636 |
| 81 | MP0005025_abnormal_response_to | 1.15925133 |
| 82 | MP0003866_abnormal_defecation | 1.12170931 |
| 83 | MP0002132_abnormal_respiratory_system | 1.11229100 |
| 84 | MP0001661_extended_life_span | 1.10092069 |
| 85 | MP0003172_abnormal_lysosome_physiology | 1.09172036 |
| 86 | MP0006036_abnormal_mitochondrial_physio | 1.08644840 |
| 87 | MP0005380_embryogenesis_phenotype | 1.07853481 |
| 88 | MP0001672_abnormal_embryogenesis/_devel | 1.07853481 |
| 89 | MP0004036_abnormal_muscle_relaxation | 1.04711458 |
| 90 | MP0005166_decreased_susceptibility_to | 1.04607856 |
| 91 | MP0004264_abnormal_extraembryonic_tissu | 1.04577818 |
| 92 | MP0003984_embryonic_growth_retardation | 1.03704630 |
| 93 | MP0010155_abnormal_intestine_physiology | 1.02304106 |
| 94 | MP0001853_heart_inflammation | 1.01980194 |
| 95 | MP0000750_abnormal_muscle_regeneration | 1.01398607 |
| 96 | MP0005076_abnormal_cell_differentiation | 1.00408971 |
| 97 | MP0005319_abnormal_enzyme/_coenzyme | 1.00402786 |
| 98 | MP0002088_abnormal_embryonic_growth/wei | 0.99296864 |
| 99 | MP0003183_abnormal_peptide_metabolism | 0.98410409 |
| 100 | MP0002095_abnormal_skin_pigmentation | 0.96935689 |
| 101 | MP0002086_abnormal_extraembryonic_tissu | 0.96100867 |
| 102 | MP0003567_abnormal_fetal_cardiomyocyte | 0.95539215 |
| 103 | MP0002405_respiratory_system_inflammati | 0.93873196 |
| 104 | MP0001849_ear_inflammation | 0.92375785 |
| 105 | MP0003890_abnormal_embryonic-extraembry | 0.91483837 |
| 106 | MP0000465_gastrointestinal_hemorrhage | 0.90417686 |
| 107 | MP0002419_abnormal_innate_immunity | 0.90261417 |
| 108 | MP0006292_abnormal_olfactory_placode | 0.89590735 |
| 109 | MP0005376_homeostasis/metabolism_phenot | 0.89521742 |
| 110 | MP0003718_maternal_effect | 0.88724546 |
| 111 | MP0009642_abnormal_blood_homeostasis | 0.88460939 |
| 112 | MP0000858_altered_metastatic_potential | 0.86819327 |
| 113 | MP0009764_decreased_sensitivity_to | 0.86248627 |
| 114 | MP0005636_abnormal_mineral_homeostasis | 0.84639760 |
| 115 | MP0001845_abnormal_inflammatory_respons | 0.82135944 |
| 116 | MP0002148_abnormal_hypersensitivity_rea | 0.81996586 |
| 117 | MP0004197_abnormal_fetal_growth/weight/ | 0.80699107 |
| 118 | MP0002085_abnormal_embryonic_tissue | 0.80250686 |
| 119 | MP0005621_abnormal_cell_physiology | 0.80068081 |
| 120 | MP0000372_irregular_coat_pigmentation | 0.79602161 |
| 121 | MP0001790_abnormal_immune_system | 0.79162012 |
| 122 | MP0005387_immune_system_phenotype | 0.79162012 |
| 123 | MP0009763_increased_sensitivity_to | 0.78928890 |
| 124 | MP0005384_cellular_phenotype | 0.77587283 |
| 125 | MP0000358_abnormal_cell_content/ | 0.77540247 |
| 126 | MP0005266_abnormal_metabolism | 0.76670724 |
| 127 | MP0002877_abnormal_melanocyte_morpholog | 0.76325319 |
| 128 | MP0001533_abnormal_skeleton_physiology | 0.73555486 |
| 129 | MP0000598_abnormal_liver_morphology | 0.72277999 |
| 130 | MP0002269_muscular_atrophy | 0.71604945 |
| 131 | MP0002933_joint_inflammation | 0.71059530 |
| 132 | MP0002249_abnormal_larynx_morphology | 0.70288439 |
| 133 | MP0009672_abnormal_birth_weight | 0.69759518 |
| 134 | MP0000749_muscle_degeneration | 0.68826393 |
| 135 | MP0002971_abnormal_brown_adipose | 0.68377336 |
| 136 | MP0003724_increased_susceptibility_to | 0.67844257 |
| 137 | MP0001243_abnormal_dermal_layer | 0.67387060 |
| 138 | MP0003646_muscle_fatigue | 0.66925510 |
| 139 | MP0001873_stomach_inflammation | 0.66705815 |
| 140 | MP0000678_abnormal_parathyroid_gland | 0.66114629 |
| 141 | MP0003300_gastrointestinal_ulcer | 0.65383089 |
| 142 | MP0002822_catalepsy | 0.63154444 |
| 143 | MP0000477_abnormal_intestine_morphology | 0.62438085 |
| 144 | MP0006035_abnormal_mitochondrial_morpho | 0.61759452 |
| 145 | MP0002210_abnormal_sex_determination | 0.61452765 |
| 146 | MP0002084_abnormal_developmental_patter | 0.61214777 |
| 147 | MP0001664_abnormal_digestion | 0.60991549 |
| 148 | MP0008873_increased_physiological_sensi | 0.60844630 |
| 149 | MP0005395_other_phenotype | 0.60600179 |
| 150 | MP0002136_abnormal_kidney_physiology | 0.59990938 |
| 151 | MP0003879_abnormal_hair_cell | 0.58976292 |
| 152 | MP0009115_abnormal_fat_cell | 0.57402459 |
| 153 | MP0002078_abnormal_glucose_homeostasis | 0.57050463 |
| 154 | MP0002166_altered_tumor_susceptibility | 0.56701762 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Hypobetalipoproteinemia (HP:0003563) | 6.15269497 |
| 2 | Complement deficiency (HP:0004431) | 5.95778793 |
| 3 | Abnormality of monocarboxylic acid metabolism (HP:0010996) | 5.81547896 |
| 4 | Prolonged partial thromboplastin time (HP:0003645) | 5.61697988 |
| 5 | Cerebellar dysplasia (HP:0007033) | 5.58131058 |
| 6 | Abnormality of complement system (HP:0005339) | 4.98571299 |
| 7 | Deep venous thrombosis (HP:0002625) | 4.85994566 |
| 8 | Systemic lupus erythematosus (HP:0002725) | 4.81396495 |
| 9 | Joint hemorrhage (HP:0005261) | 4.50211090 |
| 10 | Anterior segment dysgenesis (HP:0007700) | 4.49515586 |
| 11 | Ependymoma (HP:0002888) | 4.41043452 |
| 12 | Xanthomatosis (HP:0000991) | 4.24889820 |
| 13 | Abnormality of aromatic amino acid family metabolism (HP:0004338) | 4.10838950 |
| 14 | Abnormality of the intrinsic pathway (HP:0010989) | 4.04579438 |
| 15 | Abnormality of glutamine family amino acid metabolism (HP:0010902) | 3.99930101 |
| 16 | Abnormality of pyrimidine metabolism (HP:0004353) | 3.96199569 |
| 17 | Agnosia (HP:0010524) | 3.91467206 |
| 18 | Hyperlipoproteinemia (HP:0010980) | 3.76911221 |
| 19 | Recurrent gram-negative bacterial infections (HP:0005420) | 3.75822190 |
| 20 | Medulloblastoma (HP:0002885) | 3.68195396 |
| 21 | Type II lissencephaly (HP:0007260) | 3.54637115 |
| 22 | Hypoplasia of the capital femoral epiphysis (HP:0003090) | 3.51286091 |
| 23 | Amaurosis fugax (HP:0100576) | 3.48247330 |
| 24 | Abnormality of the heme biosynthetic pathway (HP:0010472) | 3.48054968 |
| 25 | Prostate neoplasm (HP:0100787) | 3.43983463 |
| 26 | Conjugated hyperbilirubinemia (HP:0002908) | 3.42353326 |
| 27 | Abnormal number of erythroid precursors (HP:0012131) | 3.38752344 |
| 28 | Selective tooth agenesis (HP:0001592) | 3.35979067 |
| 29 | Birth length less than 3rd percentile (HP:0003561) | 3.34899145 |
| 30 | Orchitis (HP:0100796) | 3.33061794 |
| 31 | Retrobulbar optic neuritis (HP:0100654) | 3.30778032 |
| 32 | Optic neuritis (HP:0100653) | 3.30778032 |
| 33 | Myositis (HP:0100614) | 3.20264447 |
| 34 | Hypolipoproteinemia (HP:0010981) | 3.18461169 |
| 35 | Abnormality of cells of the erythroid lineage (HP:0012130) | 3.16626948 |
| 36 | Gastrointestinal stroma tumor (HP:0100723) | 3.16277056 |
| 37 | Bundle branch block (HP:0011710) | 3.16131100 |
| 38 | Aplastic anemia (HP:0001915) | 3.01209571 |
| 39 | Eczematoid dermatitis (HP:0000976) | 3.00982684 |
| 40 | Thrombocytosis (HP:0001894) | 2.99906958 |
| 41 | Lymphoma (HP:0002665) | 2.99706772 |
| 42 | Abnormality of the level of lipoprotein cholesterol (HP:0010979) | 2.97811870 |
| 43 | Abnormality of glycine metabolism (HP:0010895) | 2.96486286 |
| 44 | Abnormality of serine family amino acid metabolism (HP:0010894) | 2.96486286 |
| 45 | IgM deficiency (HP:0002850) | 2.93125238 |
| 46 | Cerebral hypomyelination (HP:0006808) | 2.89201824 |
| 47 | Hyperglycinuria (HP:0003108) | 2.87649866 |
| 48 | B lymphocytopenia (HP:0010976) | 2.85109937 |
| 49 | Abnormality of B cell number (HP:0010975) | 2.85109937 |
| 50 | Glomerulonephritis (HP:0000099) | 2.84160015 |
| 51 | Reduced antithrombin III activity (HP:0001976) | 2.82562013 |
| 52 | Hemorrhage of the eye (HP:0011885) | 2.76926092 |
| 53 | Intrahepatic cholestasis (HP:0001406) | 2.76539096 |
| 54 | Aplasia/Hypoplasia of the capital femoral epiphysis (HP:0005003) | 2.73821655 |
| 55 | Absent epiphyses (HP:0010577) | 2.73821655 |
| 56 | Rhabdomyosarcoma (HP:0002859) | 2.70876314 |
| 57 | Fat malabsorption (HP:0002630) | 2.70572084 |
| 58 | Reticulocytopenia (HP:0001896) | 2.69207977 |
| 59 | Abnormality of the prostate (HP:0008775) | 2.69164266 |
| 60 | Hyperammonemia (HP:0001987) | 2.66169446 |
| 61 | Muscle fiber atrophy (HP:0100295) | 2.64674730 |
| 62 | Ketosis (HP:0001946) | 2.61269691 |
| 63 | Colitis (HP:0002583) | 2.59752040 |
| 64 | Wrist flexion contracture (HP:0001239) | 2.57018808 |
| 65 | Increased serum ferritin (HP:0003281) | 2.56060667 |
| 66 | Malnutrition (HP:0004395) | 2.55156391 |
| 67 | 11 pairs of ribs (HP:0000878) | 2.54976431 |
| 68 | Abnormality of the common coagulation pathway (HP:0010990) | 2.54645847 |
| 69 | Panhypogammaglobulinemia (HP:0003139) | 2.54085017 |
| 70 | Generalized aminoaciduria (HP:0002909) | 2.52952285 |
| 71 | Meningitis (HP:0001287) | 2.49822521 |
| 72 | Encephalitis (HP:0002383) | 2.47915303 |
| 73 | Hyperglycinemia (HP:0002154) | 2.47150418 |
| 74 | Basal cell carcinoma (HP:0002671) | 2.44300220 |
| 75 | Nephritis (HP:0000123) | 2.44248066 |
| 76 | Abnormality of the astrocytes (HP:0100707) | 2.42858598 |
| 77 | Astrocytoma (HP:0009592) | 2.42858598 |
| 78 | Thrombophlebitis (HP:0004418) | 2.40180933 |
| 79 | Hyperbilirubinemia (HP:0002904) | 2.39438717 |
| 80 | Abnormality of nucleobase metabolism (HP:0010932) | 2.36331585 |
| 81 | Petechiae (HP:0000967) | 2.34742284 |
| 82 | Abnormality of long-chain fatty-acid metabolism (HP:0010964) | 2.33615785 |
| 83 | Severe visual impairment (HP:0001141) | 2.33502309 |
| 84 | Hypercholesterolemia (HP:0003124) | 2.32312924 |
| 85 | Degeneration of anterior horn cells (HP:0002398) | 2.30828035 |
| 86 | Abnormality of the anterior horn cell (HP:0006802) | 2.30828035 |
| 87 | IgG deficiency (HP:0004315) | 2.30237266 |
| 88 | Type 2 muscle fiber atrophy (HP:0003554) | 2.29144123 |
| 89 | Abnormal lung lobation (HP:0002101) | 2.29143475 |
| 90 | Neoplasm of the rectum (HP:0100743) | 2.28251959 |
| 91 | Pulmonary embolism (HP:0002204) | 2.27556030 |
| 92 | Abnormality of iron homeostasis (HP:0011031) | 2.27256738 |
| 93 | Pancreatitis (HP:0001733) | 2.24348091 |
| 94 | Increased neuronal autofluorescent lipopigment (HP:0002074) | 2.23915857 |
| 95 | Chronic otitis media (HP:0000389) | 2.22328364 |
| 96 | Lymphopenia (HP:0001888) | 2.22321046 |
| 97 | Metabolic acidosis (HP:0001942) | 2.21272244 |
| 98 | Oral leukoplakia (HP:0002745) | 2.20591035 |
| 99 | Delayed CNS myelination (HP:0002188) | 2.20508455 |
| 100 | Joint swelling (HP:0001386) | 2.19638798 |
| 101 | T lymphocytopenia (HP:0005403) | 2.19025328 |
| 102 | Abnormality of cells of the lymphoid lineage (HP:0012140) | 2.19004392 |
| 103 | Hydroxyprolinuria (HP:0003080) | 2.15406318 |
| 104 | Abnormality of proline metabolism (HP:0010907) | 2.15406318 |
| 105 | Widely patent fontanelles and sutures (HP:0004492) | 2.14731171 |
| 106 | Keratoconjunctivitis sicca (HP:0001097) | 2.13499531 |
| 107 | Neoplasm of the pancreas (HP:0002894) | 2.13489424 |
| 108 | Neoplasm of the colon (HP:0100273) | 2.12610189 |
| 109 | Abnormality of T cells (HP:0002843) | 2.09929291 |
| 110 | Type I transferrin isoform profile (HP:0003642) | 2.08867044 |
| 111 | Inflammation of the large intestine (HP:0002037) | 2.07483516 |
| 112 | Long clavicles (HP:0000890) | 2.05903013 |
| 113 | Purpura (HP:0000979) | 2.05144593 |
| 114 | Acute myeloid leukemia (HP:0004808) | 2.04229889 |
| 115 | Steatorrhea (HP:0002570) | 2.04223483 |
| 116 | Gastrointestinal inflammation (HP:0004386) | 2.03752235 |
| 117 | Abnormality of vitamin metabolism (HP:0100508) | 2.02741220 |
| 118 | Anorexia (HP:0002039) | 2.02350052 |
| 119 | Glioma (HP:0009733) | 2.02217351 |
| 120 | Nasal polyposis (HP:0100582) | 2.02200852 |
| 121 | Abnormal gallbladder physiology (HP:0012438) | 2.01794614 |
| 122 | Cholecystitis (HP:0001082) | 2.01794614 |
| 123 | Chronic diarrhea (HP:0002028) | 2.01735337 |
| 124 | Gingival bleeding (HP:0000225) | 2.01502917 |
| 125 | Recurrent sinusitis (HP:0011108) | 2.00815219 |
| 126 | Abnormality of T cell number (HP:0011839) | 1.97787570 |
| 127 | Spontaneous abortion (HP:0005268) | 1.96152541 |
| 128 | Epistaxis (HP:0000421) | 1.96076716 |
| 129 | Agammaglobulinemia (HP:0004432) | 1.94567433 |
| 130 | Abnormality of transition element cation homeostasis (HP:0011030) | 1.94467629 |
| 131 | Recurrent bronchitis (HP:0002837) | 1.94126845 |
| 132 | Abnormality of sulfur amino acid metabolism (HP:0004339) | 1.93988873 |
| 133 | Acute lymphatic leukemia (HP:0006721) | 1.93726124 |
| 134 | Neoplasm of striated muscle (HP:0009728) | 1.93648005 |
| 135 | Neoplasm of the small intestine (HP:0100833) | 1.92941109 |
| 136 | Bone marrow hypocellularity (HP:0005528) | 1.92854503 |
| 137 | Vasculitis (HP:0002633) | 1.92350471 |
| 138 | Spinal rigidity (HP:0003306) | 1.92253928 |
| 139 | Rhabdomyolysis (HP:0003201) | 1.91695523 |
| 140 | Microretrognathia (HP:0000308) | 1.91522217 |
| 141 | Self-mutilation (HP:0000742) | 1.90988366 |
| 142 | Keratoconjunctivitis (HP:0001096) | 1.90185569 |
| 143 | Buphthalmos (HP:0000557) | 1.90071099 |
| 144 | Arterial thrombosis (HP:0004420) | 1.89688452 |
| 145 | Abnormality of aspartate family amino acid metabolism (HP:0010899) | 1.88654364 |
| 146 | Rough bone trabeculation (HP:0100670) | 1.87440421 |
| 147 | Nonimmune hydrops fetalis (HP:0001790) | 1.87389446 |
| 148 | Gangrene (HP:0100758) | 1.86373249 |
| 149 | Severe combined immunodeficiency (HP:0004430) | 1.85906966 |
| 150 | Premature graying of hair (HP:0002216) | 1.84174646 |
| 151 | Pallor (HP:0000980) | 1.83956936 |
| 152 | Hyperphosphaturia (HP:0003109) | 1.83576541 |
| 153 | Myelodysplasia (HP:0002863) | 1.82957784 |
| 154 | Abnormality of reticulocytes (HP:0004312) | 1.82947391 |
| 155 | Abnormal enzyme/coenzyme activity (HP:0012379) | 1.82775263 |
| 156 | Chromsome breakage (HP:0040012) | 1.82751087 |
| 157 | Abnormality of urine glucose concentration (HP:0011016) | 1.82029113 |
| 158 | Glycosuria (HP:0003076) | 1.82029113 |
| 159 | Acanthocytosis (HP:0001927) | 1.81006026 |
| 160 | Cellulitis (HP:0100658) | 1.80643343 |
| 161 | Increased cerebral lipofuscin (HP:0011813) | 1.80167510 |
| 162 | Intracellular accumulation of autofluorescent lipopigment storage material (HP:0003204) | 1.79861860 |
| 163 | Increased density of long bones (HP:0006392) | 1.79707401 |
| 164 | Prolonged bleeding time (HP:0003010) | 1.79700109 |
| 165 | Poikiloderma (HP:0001029) | 1.79400187 |
| 166 | Cellular immunodeficiency (HP:0005374) | 1.79358943 |
| 167 | Granulocytopenia (HP:0001913) | 1.78767074 |
| 168 | Neutropenia (HP:0001875) | 1.77871369 |
| 169 | Elevated alkaline phosphatase (HP:0003155) | 1.77842275 |
| 170 | Opisthotonus (HP:0002179) | 1.76706035 |
| 171 | CNS hypomyelination (HP:0003429) | 1.76301479 |
| 172 | Optic nerve coloboma (HP:0000588) | 1.76287829 |
| 173 | Elevated erythrocyte sedimentation rate (HP:0003565) | 1.76117486 |
| 174 | Abnormal urine phosphate concentration (HP:0012599) | 1.75944872 |
| 175 | Gout (HP:0001997) | 1.75497481 |
| 176 | Elevated hepatic transaminases (HP:0002910) | 1.75149248 |
| 177 | Recurrent viral infections (HP:0004429) | 1.75086557 |
| 178 | Pulmonary infiltrates (HP:0002113) | 1.74546040 |
| 179 | Chromosomal breakage induced by crosslinking agents (HP:0003221) | 1.74349664 |
| 180 | Cafe-au-lait spot (HP:0000957) | 1.73399183 |
| 181 | Epidermoid cyst (HP:0200040) | 1.73375798 |
| 182 | Abnormality of alkaline phosphatase activity (HP:0004379) | 1.73214956 |
| 183 | Recurrent abscess formation (HP:0002722) | 1.72986830 |
| 184 | Abnormality of the nasal mucosa (HP:0000433) | 1.72975077 |
| 185 | Decreased activity of mitochondrial respiratory chain (HP:0008972) | 1.71148679 |
| 186 | Abnormal activity of mitochondrial respiratory chain (HP:0011922) | 1.71148679 |
| 187 | Abnormal delayed hypersensitivity skin test (HP:0002963) | 1.70726971 |
| 188 | Biliary tract neoplasm (HP:0100574) | 1.70494431 |
| 189 | High pitched voice (HP:0001620) | 1.69805736 |
| 190 | Abnormality of T cell physiology (HP:0011840) | 1.68873574 |
| 191 | Combined immunodeficiency (HP:0005387) | 1.67455705 |
| 192 | Macrocytic anemia (HP:0001972) | 1.67235564 |
| 193 | Abnormal number of incisors (HP:0011064) | 1.67125990 |
| 194 | Emphysema (HP:0002097) | 1.66574852 |
| 195 | Abnormality of chromosome stability (HP:0003220) | 1.66287986 |
| 196 | Heart block (HP:0012722) | 1.65492391 |
| 197 | Peripheral primitive neuroectodermal neoplasm (HP:0030067) | 1.62678146 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | PIK3CG | 5.99146576 |
| 2 | BUB1 | 4.00178747 |
| 3 | MAP3K10 | 3.09194955 |
| 4 | FLT3 | 2.84398656 |
| 5 | EIF2AK1 | 2.70718817 |
| 6 | MAP4K1 | 2.51235074 |
| 7 | PRPF4B | 2.46429981 |
| 8 | CDC7 | 2.42283422 |
| 9 | NEK1 | 2.41175865 |
| 10 | EEF2K | 2.39287787 |
| 11 | SMG1 | 2.24084715 |
| 12 | FGFR4 | 2.22857478 |
| 13 | NEK2 | 2.22092493 |
| 14 | WEE1 | 2.20737292 |
| 15 | TESK2 | 2.11591664 |
| 16 | NLK | 2.10946944 |
| 17 | BRSK2 | 2.03304814 |
| 18 | TSSK6 | 1.99247283 |
| 19 | MARK3 | 1.93590251 |
| 20 | PINK1 | 1.91263133 |
| 21 | SIK1 | 1.72055461 |
| 22 | KIT | 1.68213046 |
| 23 | MAP3K1 | 1.56962321 |
| 24 | NME2 | 1.55771090 |
| 25 | ICK | 1.55581483 |
| 26 | BRSK1 | 1.53952024 |
| 27 | EPHB1 | 1.52830461 |
| 28 | MAPK15 | 1.47827582 |
| 29 | PLK1 | 1.46633299 |
| 30 | PASK | 1.43956929 |
| 31 | MAP2K3 | 1.42798163 |
| 32 | ACVR1B | 1.42297547 |
| 33 | RPS6KB2 | 1.38339780 |
| 34 | STK16 | 1.37641473 |
| 35 | BLK | 1.35383929 |
| 36 | RIPK4 | 1.33632623 |
| 37 | STK10 | 1.32983590 |
| 38 | SIK2 | 1.30090985 |
| 39 | CSF1R | 1.26440989 |
| 40 | PKN2 | 1.26210160 |
| 41 | ZAP70 | 1.25669900 |
| 42 | MAP3K14 | 1.25603145 |
| 43 | TNK2 | 1.24992743 |
| 44 | NEK9 | 1.20548214 |
| 45 | CCNB1 | 1.17356885 |
| 46 | BCKDK | 1.16298007 |
| 47 | PIM2 | 1.15397924 |
| 48 | VRK1 | 1.13758409 |
| 49 | TXK | 1.13394865 |
| 50 | AURKB | 1.12391865 |
| 51 | SCYL2 | 1.10831417 |
| 52 | TLK1 | 1.09676666 |
| 53 | EPHA3 | 1.09401275 |
| 54 | JAK3 | 1.09060656 |
| 55 | RPS6KA4 | 1.08446262 |
| 56 | TRIB3 | 1.07194300 |
| 57 | CLK1 | 1.05978590 |
| 58 | SRPK1 | 1.05416876 |
| 59 | TGFBR1 | 1.04701386 |
| 60 | IKBKE | 1.04292978 |
| 61 | ITK | 1.02999910 |
| 62 | NME1 | 1.02552211 |
| 63 | EIF2AK3 | 1.02288566 |
| 64 | CDK7 | 1.01245873 |
| 65 | MKNK1 | 1.00636174 |
| 66 | JAK1 | 1.00066404 |
| 67 | PRKCQ | 0.99990901 |
| 68 | ATR | 0.99661311 |
| 69 | TTK | 0.96633979 |
| 70 | STK4 | 0.95852183 |
| 71 | MATK | 0.95485587 |
| 72 | KDR | 0.91712041 |
| 73 | BTK | 0.91522544 |
| 74 | SIK3 | 0.90280724 |
| 75 | FGR | 0.89714967 |
| 76 | CHEK1 | 0.88828389 |
| 77 | PIK3CA | 0.88017917 |
| 78 | GRK6 | 0.86856795 |
| 79 | CDK6 | 0.83806988 |
| 80 | PLK4 | 0.82077751 |
| 81 | PBK | 0.80909750 |
| 82 | MAP3K8 | 0.80520513 |
| 83 | CDK4 | 0.79796769 |
| 84 | CSK | 0.78707704 |
| 85 | CHEK2 | 0.78494779 |
| 86 | ARAF | 0.77898860 |
| 87 | PDK1 | 0.75858890 |
| 88 | JAK2 | 0.75823658 |
| 89 | PLK3 | 0.75803196 |
| 90 | FGFR3 | 0.75429369 |
| 91 | CDC42BPA | 0.73963533 |
| 92 | CDK12 | 0.72556246 |
| 93 | PDPK1 | 0.72168065 |
| 94 | VRK2 | 0.72117237 |
| 95 | PIM1 | 0.71480578 |
| 96 | TAOK2 | 0.69026630 |
| 97 | CDK8 | 0.65619978 |
| 98 | LRRK2 | 0.65274518 |
| 99 | MAP3K11 | 0.65186280 |
| 100 | ERN1 | 0.64083263 |
| 101 | AURKA | 0.63628346 |
| 102 | MAP3K13 | 0.63067468 |
| 103 | MAP3K3 | 0.60939582 |
| 104 | TESK1 | 0.60569890 |
| 105 | PRKG2 | 0.60335410 |
| 106 | TAOK1 | 0.60144024 |
| 107 | MAP2K2 | 0.58556521 |
| 108 | PTK6 | 0.58241091 |
| 109 | SYK | 0.56575679 |
| 110 | HCK | 0.55247197 |
| 111 | BMX | 0.55122805 |
| 112 | MAP2K6 | 0.54798517 |
| 113 | LCK | 0.54670926 |
| 114 | TGFBR2 | 0.54122235 |
| 115 | IKBKB | 0.53563048 |
| 116 | TRPM7 | 0.52478712 |
| 117 | MAPKAPK3 | 0.51162156 |
| 118 | LYN | 0.51056264 |
| 119 | TEC | 0.50766163 |
| 120 | CDK2 | 0.49489401 |
| 121 | FES | 0.49231091 |
| 122 | RPS6KA5 | 0.48036135 |
| 123 | TTN | 0.47666886 |
| 124 | OBSCN | 0.45020141 |
| 125 | PAK4 | 0.44852331 |
| 126 | HIPK2 | 0.44826808 |
| 127 | ATM | 0.43371546 |
| 128 | MAPK11 | 0.43319212 |
| 129 | TBK1 | 0.42790611 |
| 130 | TYK2 | 0.42630704 |
| 131 | CSNK2A1 | 0.42542091 |
| 132 | STK24 | 0.42116927 |
| 133 | RIPK1 | 0.41557274 |
| 134 | MAPK12 | 0.41322820 |
| 135 | MELK | 0.41293828 |
| 136 | IRAK3 | 0.40486210 |
| 137 | CSNK2A2 | 0.38783412 |
| 138 | BRD4 | 0.38414999 |
| 139 | ALK | 0.36949820 |
| 140 | ZAK | 0.36720380 |
| 141 | RPS6KL1 | 0.36353669 |
| 142 | RPS6KC1 | 0.36353669 |
| 143 | CAMK4 | 0.36188356 |
| 144 | CHUK | 0.33999068 |
| 145 | RPS6KA6 | 0.33117698 |
| 146 | IRAK4 | 0.33025203 |
| 147 | CDK1 | 0.32711107 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | DNA replication_Homo sapiens_hsa03030 | 4.58845018 |
| 2 | Mismatch repair_Homo sapiens_hsa03430 | 4.26539398 |
| 3 | Phenylalanine, tyrosine and tryptophan biosynthesis_Homo sapiens_hsa00400 | 3.69793918 |
| 4 | Spliceosome_Homo sapiens_hsa03040 | 3.18767917 |
| 5 | Ribosome biogenesis in eukaryotes_Homo sapiens_hsa03008 | 3.07129925 |
| 6 | Ribosome_Homo sapiens_hsa03010 | 3.06439675 |
| 7 | Base excision repair_Homo sapiens_hsa03410 | 2.96445475 |
| 8 | Proteasome_Homo sapiens_hsa03050 | 2.89244508 |
| 9 | Retinol metabolism_Homo sapiens_hsa00830 | 2.83806918 |
| 10 | Homologous recombination_Homo sapiens_hsa03440 | 2.82898045 |
| 11 | Complement and coagulation cascades_Homo sapiens_hsa04610 | 2.78423809 |
| 12 | Drug metabolism - cytochrome P450_Homo sapiens_hsa00982 | 2.77341368 |
| 13 | RNA transport_Homo sapiens_hsa03013 | 2.57420533 |
| 14 | Chemical carcinogenesis_Homo sapiens_hsa05204 | 2.57327562 |
| 15 | Metabolism of xenobiotics by cytochrome P450_Homo sapiens_hsa00980 | 2.50821638 |
| 16 | Primary bile acid biosynthesis_Homo sapiens_hsa00120 | 2.48456348 |
| 17 | Aminoacyl-tRNA biosynthesis_Homo sapiens_hsa00970 | 2.42408763 |
| 18 | Cell cycle_Homo sapiens_hsa04110 | 2.37982175 |
| 19 | Nucleotide excision repair_Homo sapiens_hsa03420 | 2.37444350 |
| 20 | One carbon pool by folate_Homo sapiens_hsa00670 | 2.32818471 |
| 21 | Phenylalanine metabolism_Homo sapiens_hsa00360 | 2.30056298 |
| 22 | Ascorbate and aldarate metabolism_Homo sapiens_hsa00053 | 2.29831148 |
| 23 | Arginine biosynthesis_Homo sapiens_hsa00220 | 2.28156959 |
| 24 | RNA polymerase_Homo sapiens_hsa03020 | 2.24368632 |
| 25 | Fatty acid degradation_Homo sapiens_hsa00071 | 2.15429485 |
| 26 | Non-homologous end-joining_Homo sapiens_hsa03450 | 2.04574919 |
| 27 | Pyrimidine metabolism_Homo sapiens_hsa00240 | 2.02359873 |
| 28 | Pentose and glucuronate interconversions_Homo sapiens_hsa00040 | 2.00882048 |
| 29 | Glyoxylate and dicarboxylate metabolism_Homo sapiens_hsa00630 | 1.98010360 |
| 30 | Steroid hormone biosynthesis_Homo sapiens_hsa00140 | 1.89635019 |
| 31 | Histidine metabolism_Homo sapiens_hsa00340 | 1.83629099 |
| 32 | RNA degradation_Homo sapiens_hsa03018 | 1.83425680 |
| 33 | Fat digestion and absorption_Homo sapiens_hsa04975 | 1.82950351 |
| 34 | Vitamin digestion and absorption_Homo sapiens_hsa04977 | 1.76472181 |
| 35 | Fanconi anemia pathway_Homo sapiens_hsa03460 | 1.76020972 |
| 36 | Tyrosine metabolism_Homo sapiens_hsa00350 | 1.71758454 |
| 37 | Primary immunodeficiency_Homo sapiens_hsa05340 | 1.68747494 |
| 38 | Staphylococcus aureus infection_Homo sapiens_hsa05150 | 1.65314923 |
| 39 | Starch and sucrose metabolism_Homo sapiens_hsa00500 | 1.64121726 |
| 40 | Tryptophan metabolism_Homo sapiens_hsa00380 | 1.62879016 |
| 41 | Linoleic acid metabolism_Homo sapiens_hsa00591 | 1.56964945 |
| 42 | Citrate cycle (TCA cycle)_Homo sapiens_hsa00020 | 1.54440537 |
| 43 | PPAR signaling pathway_Homo sapiens_hsa03320 | 1.53083189 |
| 44 | Other glycan degradation_Homo sapiens_hsa00511 | 1.43241972 |
| 45 | Butanoate metabolism_Homo sapiens_hsa00650 | 1.38267479 |
| 46 | Epstein-Barr virus infection_Homo sapiens_hsa05169 | 1.37439922 |
| 47 | mRNA surveillance pathway_Homo sapiens_hsa03015 | 1.34943203 |
| 48 | Basal transcription factors_Homo sapiens_hsa03022 | 1.34275136 |
| 49 | Biosynthesis of amino acids_Homo sapiens_hsa01230 | 1.33296312 |
| 50 | Bile secretion_Homo sapiens_hsa04976 | 1.29689475 |
| 51 | Renin-angiotensin system_Homo sapiens_hsa04614 | 1.24542003 |
| 52 | Selenocompound metabolism_Homo sapiens_hsa00450 | 1.22804444 |
| 53 | Porphyrin and chlorophyll metabolism_Homo sapiens_hsa00860 | 1.22565619 |
| 54 | p53 signaling pathway_Homo sapiens_hsa04115 | 1.20302696 |
| 55 | Central carbon metabolism in cancer_Homo sapiens_hsa05230 | 1.19824051 |
| 56 | Peroxisome_Homo sapiens_hsa04146 | 1.18213268 |
| 57 | Pentose phosphate pathway_Homo sapiens_hsa00030 | 1.17307696 |
| 58 | Arachidonic acid metabolism_Homo sapiens_hsa00590 | 1.16999392 |
| 59 | Acute myeloid leukemia_Homo sapiens_hsa05221 | 1.16574119 |
| 60 | B cell receptor signaling pathway_Homo sapiens_hsa04662 | 1.14756165 |
| 61 | Valine, leucine and isoleucine degradation_Homo sapiens_hsa00280 | 1.13344097 |
| 62 | Viral carcinogenesis_Homo sapiens_hsa05203 | 1.12078458 |
| 63 | Folate biosynthesis_Homo sapiens_hsa00790 | 1.10593513 |
| 64 | Herpes simplex infection_Homo sapiens_hsa05168 | 1.05835641 |
| 65 | Cysteine and methionine metabolism_Homo sapiens_hsa00270 | 1.05147990 |
| 66 | Purine metabolism_Homo sapiens_hsa00230 | 1.04005115 |
| 67 | Fructose and mannose metabolism_Homo sapiens_hsa00051 | 1.02548672 |
| 68 | Legionellosis_Homo sapiens_hsa05134 | 1.01950910 |
| 69 | 2-Oxocarboxylic acid metabolism_Homo sapiens_hsa01210 | 0.98266339 |
| 70 | Antigen processing and presentation_Homo sapiens_hsa04612 | 0.92835858 |
| 71 | HTLV-I infection_Homo sapiens_hsa05166 | 0.92637532 |
| 72 | Progesterone-mediated oocyte maturation_Homo sapiens_hsa04914 | 0.90721455 |
| 73 | Carbon metabolism_Homo sapiens_hsa01200 | 0.88588604 |
| 74 | Cytosolic DNA-sensing pathway_Homo sapiens_hsa04623 | 0.87724787 |
| 75 | Pyruvate metabolism_Homo sapiens_hsa00620 | 0.87006132 |
| 76 | Measles_Homo sapiens_hsa05162 | 0.84851839 |
| 77 | Systemic lupus erythematosus_Homo sapiens_hsa05322 | 0.84086692 |
| 78 | Apoptosis_Homo sapiens_hsa04210 | 0.83241756 |
| 79 | Other types of O-glycan biosynthesis_Homo sapiens_hsa00514 | 0.83018907 |
| 80 | Colorectal cancer_Homo sapiens_hsa05210 | 0.82388668 |
| 81 | Glycolysis / Gluconeogenesis_Homo sapiens_hsa00010 | 0.80963094 |
| 82 | Alanine, aspartate and glutamate metabolism_Homo sapiens_hsa00250 | 0.80616103 |
| 83 | Maturity onset diabetes of the young_Homo sapiens_hsa04950 | 0.79399468 |
| 84 | Small cell lung cancer_Homo sapiens_hsa05222 | 0.77616904 |
| 85 | Hepatitis B_Homo sapiens_hsa05161 | 0.71312846 |
| 86 | Chronic myeloid leukemia_Homo sapiens_hsa05220 | 0.70578851 |
| 87 | Drug metabolism - other enzymes_Homo sapiens_hsa00983 | 0.70403408 |
| 88 | Cyanoamino acid metabolism_Homo sapiens_hsa00460 | 0.70035452 |
| 89 | Fatty acid metabolism_Homo sapiens_hsa01212 | 0.70033253 |
| 90 | Fc epsilon RI signaling pathway_Homo sapiens_hsa04664 | 0.69370565 |
| 91 | Ubiquinone and other terpenoid-quinone biosynthesis_Homo sapiens_hsa00130 | 0.68786087 |
| 92 | Sulfur relay system_Homo sapiens_hsa04122 | 0.68642565 |
| 93 | Pantothenate and CoA biosynthesis_Homo sapiens_hsa00770 | 0.67471005 |
| 94 | Arginine and proline metabolism_Homo sapiens_hsa00330 | 0.67376590 |
| 95 | Pathogenic Escherichia coli infection_Homo sapiens_hsa05130 | 0.65278605 |
| 96 | Prion diseases_Homo sapiens_hsa05020 | 0.62468291 |
| 97 | Thyroid cancer_Homo sapiens_hsa05216 | 0.61977934 |
| 98 | Influenza A_Homo sapiens_hsa05164 | 0.61908558 |
| 99 | Protein export_Homo sapiens_hsa03060 | 0.61644423 |
| 100 | Fc gamma R-mediated phagocytosis_Homo sapiens_hsa04666 | 0.61301056 |
| 101 | HIF-1 signaling pathway_Homo sapiens_hsa04066 | 0.59784818 |
| 102 | Adipocytokine signaling pathway_Homo sapiens_hsa04920 | 0.57716946 |
| 103 | T cell receptor signaling pathway_Homo sapiens_hsa04660 | 0.57705863 |
| 104 | Inflammatory bowel disease (IBD)_Homo sapiens_hsa05321 | 0.57041675 |
| 105 | Hematopoietic cell lineage_Homo sapiens_hsa04640 | 0.55760601 |
| 106 | Protein processing in endoplasmic reticulum_Homo sapiens_hsa04141 | 0.55257437 |
| 107 | Ubiquitin mediated proteolysis_Homo sapiens_hsa04120 | 0.54611554 |
| 108 | N-Glycan biosynthesis_Homo sapiens_hsa00510 | 0.54273843 |
| 109 | NF-kappa B signaling pathway_Homo sapiens_hsa04064 | 0.53705788 |
| 110 | Glycerolipid metabolism_Homo sapiens_hsa00561 | 0.53248911 |
| 111 | Oocyte meiosis_Homo sapiens_hsa04114 | 0.53208990 |
| 112 | Non-small cell lung cancer_Homo sapiens_hsa05223 | 0.53129147 |
| 113 | Proximal tubule bicarbonate reclamation_Homo sapiens_hsa04964 | 0.51583353 |
| 114 | Natural killer cell mediated cytotoxicity_Homo sapiens_hsa04650 | 0.51320592 |
| 115 | Glutathione metabolism_Homo sapiens_hsa00480 | 0.50129414 |
| 116 | Pertussis_Homo sapiens_hsa05133 | 0.49318988 |
| 117 | Mineral absorption_Homo sapiens_hsa04978 | 0.48369826 |
| 118 | Transcriptional misregulation in cancer_Homo sapiens_hsa05202 | 0.48000375 |
| 119 | Insulin resistance_Homo sapiens_hsa04931 | 0.47496851 |
| 120 | ABC transporters_Homo sapiens_hsa02010 | 0.47061881 |
| 121 | beta-Alanine metabolism_Homo sapiens_hsa00410 | 0.46349477 |
| 122 | Pancreatic cancer_Homo sapiens_hsa05212 | 0.46001142 |
| 123 | Lysine degradation_Homo sapiens_hsa00310 | 0.45704356 |
| 124 | Butirosin and neomycin biosynthesis_Homo sapiens_hsa00524 | 0.44079753 |
| 125 | Intestinal immune network for IgA production_Homo sapiens_hsa04672 | 0.42328073 |
| 126 | Leishmaniasis_Homo sapiens_hsa05140 | 0.40890929 |
| 127 | Galactose metabolism_Homo sapiens_hsa00052 | 0.40132616 |
| 128 | Metabolic pathways_Homo sapiens_hsa01100 | 0.40099722 |
| 129 | Glucagon signaling pathway_Homo sapiens_hsa04922 | 0.38769349 |
| 130 | Propanoate metabolism_Homo sapiens_hsa00640 | 0.38684919 |
| 131 | Vitamin B6 metabolism_Homo sapiens_hsa00750 | 0.38638921 |
| 132 | Notch signaling pathway_Homo sapiens_hsa04330 | 0.38176365 |
| 133 | Jak-STAT signaling pathway_Homo sapiens_hsa04630 | 0.36123524 |
| 134 | Bacterial invasion of epithelial cells_Homo sapiens_hsa05100 | 0.35299159 |
| 135 | Platelet activation_Homo sapiens_hsa04611 | 0.35265754 |
| 136 | Biosynthesis of unsaturated fatty acids_Homo sapiens_hsa01040 | 0.35059038 |
| 137 | Allograft rejection_Homo sapiens_hsa05330 | 0.34527372 |
| 138 | AGE-RAGE signaling pathway in diabetic complications_Homo sapiens_hsa04933 | 0.34106401 |
| 139 | Osteoclast differentiation_Homo sapiens_hsa04380 | 0.33639229 |
| 140 | mTOR signaling pathway_Homo sapiens_hsa04150 | 0.32198189 |
| 141 | Glycine, serine and threonine metabolism_Homo sapiens_hsa00260 | 0.32060904 |
| 142 | RIG-I-like receptor signaling pathway_Homo sapiens_hsa04622 | 0.31954962 |
| 143 | VEGF signaling pathway_Homo sapiens_hsa04370 | 0.31697207 |
| 144 | Shigellosis_Homo sapiens_hsa05131 | 0.30902756 |
| 145 | Viral myocarditis_Homo sapiens_hsa05416 | 0.30902734 |
| 146 | Carbohydrate digestion and absorption_Homo sapiens_hsa04973 | 0.30043869 |
| 147 | Synthesis and degradation of ketone bodies_Homo sapiens_hsa00072 | 0.29523178 |
| 148 | Caffeine metabolism_Homo sapiens_hsa00232 | 0.29516043 |
| 149 | Toll-like receptor signaling pathway_Homo sapiens_hsa04620 | 0.29187295 |
| 150 | Leukocyte transendothelial migration_Homo sapiens_hsa04670 | 0.28402209 |
| 151 | Autoimmune thyroid disease_Homo sapiens_hsa05320 | 0.28145305 |
| 152 | Chagas disease (American trypanosomiasis)_Homo sapiens_hsa05142 | 0.26971487 |
| 153 | Toxoplasmosis_Homo sapiens_hsa05145 | 0.26100092 |
| 154 | Amino sugar and nucleotide sugar metabolism_Homo sapiens_hsa00520 | 0.25793353 |
| 155 | Glycosaminoglycan biosynthesis - chondroitin sulfate / dermatan sulfate_Homo sapiens_hsa00532 | 0.25620163 |
| 156 | TNF signaling pathway_Homo sapiens_hsa04668 | 0.25070138 |
| 157 | Sulfur metabolism_Homo sapiens_hsa00920 | 0.23585795 |
| 158 | Fatty acid biosynthesis_Homo sapiens_hsa00061 | 0.21646692 |
| 159 | Graft-versus-host disease_Homo sapiens_hsa05332 | 0.20161455 |
| 160 | Hepatitis C_Homo sapiens_hsa05160 | 0.20093450 |
| 161 | Glycerophospholipid metabolism_Homo sapiens_hsa00564 | 0.18652489 |
| 162 | Tuberculosis_Homo sapiens_hsa05152 | 0.16232259 |

